Migraine is far more than a simple headache; it is a disabling neurological disorder characterized by throbbing head pain, often accompanied by sensitivity to light and sound, and nausea. A migraine attack can hijack a person’s routine, forcing them to retreat from work, social obligations, and family life. The unpredictability of these attacks contributes significantly to anxiety and reduced quality of life.

Treating migraine is vital because it can prevent the episodic attacks from escalating into a chronic condition and significantly reduces the personal and professional burden. Treatment approaches are divided into two distinct categories: acute (or abortive) treatments, which stop an attack in progress, and preventive treatments, which reduce the frequency and severity of attacks over time. Medication choices depend heavily on how often the attacks occur, their severity, and the patient’s response to initial therapies (National Institute of Neurological Disorders and Stroke, 2023).

Overview of treatment options for Migraine

The overall strategy for migraine management is dual-action. Medications are needed to address immediate pain (acute phase), but they are also needed to stabilize the nervous system and decrease the likelihood of future attacks (preventive phase). Lifestyle adjustments, such as trigger avoidance, consistent sleep, and diet management, are supportive measures, but medication is generally necessary for moderate or severe cases.

Treatment is highly personalized, especially for chronic migraine (15 or more headache days per month), which requires a more aggressive preventive approach compared to episodic migraine (fewer than 15 days per month). The main goal is achieving effective relief within two hours of onset for acute attacks and reducing migraine frequency by at least 50% for preventive therapies.

Medications used for Migraine

Medications for migraine fall into several key classes:

  • Acute/Abortive Treatments: These are taken immediately upon feeling a migraine attack begin. Simple over-the-counter pain relievers (like NSAIDs) may be effective for mild migraines. For moderate to severe attacks, migraine-specific prescription drugs are needed.
    • Triptans: Drugs like sumatriptan and rizatriptan are primary treatments used to reverse the migraine process.
    • CGRP Receptor Antagonists (Gepants): Newer medications, such as ubrogepant, block the action of a specific pain-inducing protein in the brain.
    • Ditans: Medications like lasmiditan are newer options that target serotonin receptors specifically involved in migraine pain.
  • Preventive Treatments: These are taken daily or administered monthly/quarterly to reduce the frequency and severity of attacks.
    • Traditional Orals: Medications originally used for other conditions, such as beta-blockers (propranolol) or anticonvulsants (topiramate), are effective stabilizers.
    • CGRP Monoclonal Antibodies (Mabs): Drugs like erenumab are specific injectable biologics that target the CGRP pathway. Clinical guidelines recommend utilizing migraine-specific acute medications, like triptans, early in an attack to maximize efficacy.

Patients can expect acute treatments to work quickly, often within 30 minutes to two hours. However, preventive medications typically require several weeks or months of consistent use to demonstrate a significant reduction in attack frequency.

How these medications work

Migraine treatments target different phases of the cascade. Triptans constrict swollen blood vessels and block inflammatory chemicals by binding to serotonin receptors.

Newer treatments, like Gepants and Mabs, focus on Calcitonin Gene-Related Peptide (CGRP), a neurochemical that causes inflammation and pain. Mabs neutralize CGRP or its receptor to prevent pain. Traditional preventives, like anticonvulsants, calm overactive nerve cells to stop the electrical storm that starts a migraine (American Migraine Foundation, 2020).

Side effects and safety considerations

Migraine medications have potential side effects. Triptans can cause temporary chest/throat/neck tightness (“triptan sensation”) or dizziness and are usually avoided in patients with heart disease or uncontrolled high blood pressure. Traditional preventives may cause fatigue, weight changes, or “brain fog.”

A major risk is medication overuse headache (“rebound headache”) from taking acute treatments too often; patients should limit use to two to three days per week. Seek immediate medical care for the “worst headache of their life” or new neurological symptoms like weakness or confusion (Mayo Clinic, 2023).

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American Migraine Foundation. https://americanmigrainefoundation.org
  2. Mayo Clinic. https://www.mayoclinic.org
  3. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov
  4. Food and Drug Administration. https://www.fda.gov

Medications for Migraine

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Migraine.

Found 22 Approved Drugs for Migraine

SUMAtriptan

Brand Names
Migranow, Zembrace SymTouch, Onzetra Xsail, Tosymra, Imitrex, Treximet

SUMAtriptan

Brand Names
Migranow, Zembrace SymTouch, Onzetra Xsail, Tosymra, Imitrex, Treximet
Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan tablets, reconsider the diagnosis of migraine before sumatriptan tablets are administered to treat any subsequent attacks. Sumatriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of sumatriptan tablets have not been established for cluster headache. Sumatriptan tablets are a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. ( 1 ) Not indicated for the prophylactic therapy of migraine attacks. ( 1 ) Not indicated for the treatment of cluster headache. ( 1 )

Topiramate

Brand Names
Eprontia, Topamax, Trokendi, Qsymia, Phentermine, Qudexy

Topiramate

Brand Names
Eprontia, Topamax, Trokendi, Qsymia, Phentermine, Qudexy
QUDEXY XR is indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.

Rizatriptan

Brand Names
Maxalt-Mlt, Maxalt

Rizatriptan

Brand Names
Maxalt-Mlt, Maxalt
Rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets are administered to treat any subsequent attacks., Rizatriptan benzoate orally disintegrating tablets are not indicated for use in the management of hemiplegic or basilar migraine., Rizatriptan benzoate orally disintegrating tablets are not indicated for the prevention of migraine attacks., Safety and effectiveness of rizatriptan benzoate orally disintegrating tablets have not been established for cluster headache. Rizatriptan benzoate is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age ( 1 ) Limitations of Use:, Use only after clear diagnosis of migraine has been established ( 1 ), Not indicated for the prophylactic therapy of migraine ( 1 ), Not indicated for the treatment of cluster headache ( 1 )

Meloxicam

Brand Names
Xifyrm, Symbravo, Qamzova

Meloxicam

Brand Names
Xifyrm, Symbravo, Qamzova
Meloxicam oral suspension is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA).

Valproic

Generic Name
Valproic

Valproic

Generic Name
Valproic
Valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. SEE FOR STATEMENT REGARDING FATAL HEPATIC DYSFUNCTION. WARNINGS.
Showing 1-5 of 22
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances